Okuyama R - Search Results

1

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.

Teitz-Tennenbaum S, Li Q, Okuyama R, Davis MA, Sun R, Whitfield J, Knibbs RN, Stoolman LM, Chang AE. Teitz-Tennenbaum S, et al. Among authors: okuyama r. J Immunother. 2008 May;31(4):345-58. doi: 10.1097/CJI.0b013e318163628c. J Immunother. 2008. PMID: 18391761 Free PMC article.

2

Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.

Ito F, Li Q, Shreiner AB, Okuyama R, Jure-Kunkel MN, Teitz-Tennenbaum S, Chang AE. Ito F, et al. Among authors: okuyama r. Cancer Res. 2004 Nov 15;64(22):8411-9. doi: 10.1158/0008-5472.CAN-04-0590. Cancer Res. 2004. PMID: 15548712

3

[The case of tumor escape mechanism by changing their tumor-associated antigens].

Suzuki R, Kotera Y, Takeshita N, Matsushita N, Okuyama R, Aruga A, Yamamoto M. Suzuki R, et al. Among authors: okuyama r. Gan To Kagaku Ryoho. 2009 Nov;36(12):1988-90. Gan To Kagaku Ryoho. 2009. PMID: 20037300 Japanese.

4

Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer.

Aruga A, Takeshita N, Kotera Y, Okuyama R, Matsushita N, Ohta T, Takeda K, Yamamoto M. Aruga A, et al. Among authors: okuyama r. Clin Cancer Res. 2013 Apr 15;19(8):2224-31. doi: 10.1158/1078-0432.CCR-12-3592. Epub 2013 Mar 11. Clin Cancer Res. 2013. PMID: 23479678 Clinical Trial.

5

Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients.

Okuyama R, Aruga A, Hatori T, Takeda K, Yamamoto M. Okuyama R, et al. Oncoimmunology. 2013 Nov 1;2(11):e27010. doi: 10.4161/onci.27010. Epub 2013 Nov 5. Oncoimmunology. 2013. PMID: 24498547 Free PMC article.

6

Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer.

Aruga A, Takeshita N, Kotera Y, Okuyama R, Matsushita N, Ohta T, Takeda K, Yamamoto M. Aruga A, et al. Among authors: okuyama r. J Transl Med. 2014 Mar 7;12:61. doi: 10.1186/1479-5876-12-61. J Transl Med. 2014. PMID: 24606884 Free PMC article. Clinical Trial.

7

Phase I trial of Wilms' Tumor 1 (WT1) peptide vaccine with GM-CSF or CpG in patients with solid malignancy.

Ohno S, Okuyama R, Aruga A, Sugiyama H, Yamamoto M. Ohno S, et al. Among authors: okuyama r. Anticancer Res. 2012 Jun;32(6):2263-9. Anticancer Res. 2012. PMID: 22641661 Clinical Trial.

8

Determination of chronic inflammatory states in cancer patients using assay of reactive oxygen species production by neutrophils.

Suzuki Y, Ohno S, Okuyama R, Aruga A, Yamamoto M, Miura S, Yoshioka H, Mori Y, Suzuki K. Suzuki Y, et al. Among authors: okuyama r. Anticancer Res. 2012 Feb;32(2):565-70. Anticancer Res. 2012. PMID: 22287746

9

Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.

Nakamura A, Nakajima G, Okuyama R, Kuramochi H, Kondoh Y, Kanemura T, Takechi T, Yamamoto M, Hayashi K. Nakamura A, et al. Among authors: okuyama r. Gastric Cancer. 2014 Jan;17(1):188-95. doi: 10.1007/s10120-013-0249-7. Epub 2013 Mar 15. Gastric Cancer. 2014. PMID: 23494117 Free PMC article.

10

Effect of green tea extract on reactive oxygen species produced by neutrophils from cancer patients.

Suzuki K, Ohno S, Suzuki Y, Ohno Y, Okuyama R, Aruga A, Yamamoto M, Ishihara KO, Nozaki T, Miura S, Yoshioka H, Mori Y. Suzuki K, et al. Among authors: okuyama r. Anticancer Res. 2012 Jun;32(6):2369-75. Anticancer Res. 2012. PMID: 22641677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters